Literature DB >> 22763957

Estimation of treatment effect under non-proportional hazards and conditionally independent censoring.

Adam P Boyd1, John M Kittelson, Daniel L Gillen.   

Abstract

In clinical trials with time-to-event outcomes, it is common to estimate the marginal hazard ratio from the proportional hazards model, even when the proportional hazards assumption is not valid. This is unavoidable from the perspective that the estimator must be specified a priori if probability statements about treatment effect estimates are desired. Marginal hazard ratio estimates under non-proportional hazards are still useful, as they can be considered to be average treatment effect estimates over the support of the data. However, as many have shown, under non-proportional hazard, the 'usual' unweighted marginal hazard ratio estimate is a function of the censoring distribution, which is not normally considered to be scientifically relevant when describing the treatment effect. In addition, in many practical settings, the censoring distribution is only conditionally independent (e.g., differing across treatment arms), which further complicates the interpretation. In this paper, we investigate an estimator of the hazard ratio that removes the influence of censoring and propose a consistent robust variance estimator. We compare the coverage probability of the estimator to both the usual Cox model estimator and an estimator proposed by Xu and O'Quigley (2000) when censoring is independent of the covariate. The new estimator should be used for inference that does not depend on the censoring distribution. It is particularly relevant to adaptive clinical trials where, by design, censoring distributions differ across treatment arms.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22763957      PMCID: PMC3876422          DOI: 10.1002/sim.5440

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  7 in total

1.  Randomized play-the-winner clinical trials: review and recommendations.

Authors:  W F Rosenberger
Journal:  Control Clin Trials       Date:  1999-08

2.  Correcting for noncompliance and dependent censoring in an AIDS Clinical Trial with inverse probability of censoring weighted (IPCW) log-rank tests.

Authors:  J M Robins; D M Finkelstein
Journal:  Biometrics       Date:  2000-09       Impact factor: 2.571

3.  Estimating average regression effect under non-proportional hazards.

Authors:  R Xu; J O'Quigley
Journal:  Biostatistics       Date:  2000-12       Impact factor: 5.899

4.  Interim analysis on survival data: its potential bias and how to repair it.

Authors:  Hans C van Houwelingen; Cornelis J H van de Velde; Theo Stijnen
Journal:  Stat Med       Date:  2005-09-30       Impact factor: 2.373

5.  The separation of timescales in Bayesian survival modeling of the time-varying effect of a time-dependent exposure.

Authors:  Sebastien J-P A Haneuse; Kyle D Rudser; Daniel L Gillen
Journal:  Biostatistics       Date:  2007-11-19       Impact factor: 5.899

Review 6.  The use of response-adaptive designs in clinical trials.

Authors:  W F Rosenberger; J M Lachin
Journal:  Control Clin Trials       Date:  1993-12

7.  RSR13 plus cranial radiation therapy in patients with brain metastases: comparison with the Radiation Therapy Oncology Group Recursive Partitioning Analysis Brain Metastases Database.

Authors:  Edward Shaw; Charles Scott; John Suh; Sidney Kadish; Baldassarre Stea; John Hackman; Andrew Pearlman; Kevin Murray; Laurie Gaspar; Minesh Mehta; Walter Curran; Michael Gerber
Journal:  J Clin Oncol       Date:  2003-06-15       Impact factor: 44.544

  7 in total
  6 in total

1.  Robust inference in discrete hazard models for randomized clinical trials.

Authors:  Vinh Q Nguyen; Daniel L Gillen
Journal:  Lifetime Data Anal       Date:  2012-07-19       Impact factor: 1.588

2.  Censoring-robust time-dependent receiver operating characteristic curve estimators.

Authors:  Michelle M Nuño; Daniel L Gillen
Journal:  Stat Med       Date:  2021-10-17       Impact factor: 2.373

Review 3.  A Review of Causal Inference for External Comparator Arm Studies.

Authors:  Gerd Rippin; Nicolás Ballarini; Héctor Sanz; Joan Largent; Chantal Quinten; Francesco Pignatti
Journal:  Drug Saf       Date:  2022-07-27       Impact factor: 5.228

4.  Censoring-robust estimation in observational survival studies: Assessing the relative effectiveness of vascular access type on patency among end-stage renal disease patients.

Authors:  Vinh Q Nguyen; Daniel L Gillen
Journal:  Stat Biosci       Date:  2016-08-18

5.  Semiparametric Contrasts of Cumulative Pre-Treatment Mortality in the Presence of Dependent Censoring.

Authors:  Qi Gong; Douglas E Schaubel
Journal:  Stat Biosci       Date:  2014-07-02

6.  Covariate adjustment using propensity scores for dependent censoring problems in the accelerated failure time model.

Authors:  Youngjoo Cho; Chen Hu; Debashis Ghosh
Journal:  Stat Med       Date:  2017-10-10       Impact factor: 2.373

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.